Literature DB >> 3057896

Hepatic metabolism of insulin.

W C Duckworth1, F G Hamel, D E Peavy.   

Abstract

The liver plays a major role in the metabolism of insulin, but the precise cellular mechanisms, the enzymes involved, and the products generated have only recently become clarified. The initial step in insulin degradation by the liver is binding to a cell membrane receptor, following which some insulin is degraded and the products released into the incubation medium, whereas some insulin is internalized and degraded intracellularly. Recently, it has been demonstrated that the degradation of insulin by hepatocytes produces products identical to those generated by the enzyme insulin protease. With both enzyme and intact hepatocytes, two A-chain cleavages and four major and three minor B-chain cleavages occur in intact insulin. It has also been demonstrated that internalized insulin is degraded in early endosomes, primarily by cleavages in the B chain and occurring prior to acidification of the endosome and thus prior to dissociation of insulin from its receptor. The initial cleavages in the B chain of insulin occur in the same sites as are cleaved by insulin protease, supporting a role for this enzyme, both in the extracellular and intracellular metabolism of insulin. These findings also indicate that lysosomes probably play a minor or secondary role for hepatic insulin metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3057896     DOI: 10.1016/0002-9343(88)90399-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  21 in total

1.  Disorders of glucose metabolism: post mortem analyses in forensic cases--part II.

Authors:  Frank Musshoff; Cornelius Hess; Burkhard Madea
Journal:  Int J Legal Med       Date:  2010-10-07       Impact factor: 2.686

2.  Insulin clearance is different in men and women.

Authors:  Michael D Jensen; Soren Nielsen; Nidhi Gupta; Rita Basu; Robert A Rizza
Journal:  Metabolism       Date:  2011-10-13       Impact factor: 8.694

3.  Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes.

Authors:  Tomislav Bulum; Branko Kolarić; Lea Duvnjak; Marko Duvnjak
Journal:  Dig Dis Sci       Date:  2011-07-07       Impact factor: 3.199

4.  ICAM-1 and beta2 integrin deficiency impairs fat oxidation and insulin metabolism during fasting.

Authors:  Aleksandar M Babic; Hong-Wei Wang; Margaret J Lai; Thomas G Daniels; Thomas W Felbinger; Peter C Burger; Alain Stricker-Krongrad; Denisa D Wagner
Journal:  Mol Med       Date:  2004 Jul-Dec       Impact factor: 6.354

5.  High alanine aminotransferase level as a predictor for the incidence of macrovascular disease in type 2 diabetic patients with fatty liver disease.

Authors:  Megumi Inoue; Junya Oribe; Masataka Seike; Takayuki Masaki; Mizuki Endo; Masanori Tokoro; Mie Yoshihara; Koichi Honda; Rie Shin; Katsunari Abe; Nobuyuki Abe; Hironobu Yoshimatsu
Journal:  Hepatol Int       Date:  2012-04-05       Impact factor: 6.047

6.  Phosphoenolpyruvate carboxykinase (Pck1) helps regulate the triglyceride/fatty acid cycle and development of insulin resistance in mice.

Authors:  Carrie A Millward; David Desantis; Chang-Wen Hsieh; Jason D Heaney; Sorana Pisano; Yael Olswang; Lea Reshef; Michelle Beidelschies; Michelle Puchowicz; Colleen M Croniger
Journal:  J Lipid Res       Date:  2010-02-02       Impact factor: 5.922

7.  Effects of the Cellcultured Acanthopanax senticosus Extract on Antioxidative Defense System and Membrane Fluidity in the Liver of Type 2 Diabetes Mouse.

Authors:  Jung-Hee Hong; Youn-Soo Cha; Soon-Jae Rhee
Journal:  J Clin Biochem Nutr       Date:  2009-06-30       Impact factor: 3.114

8.  The early effect of sunitinib on insulin clearance in patients with metastatic renal cell carcinoma.

Authors:  Anna Maria J Thijs; Cees J Tack; Winette T A van der Graaf; Gerard A Rongen; Carla M L van Herpen
Journal:  Br J Clin Pharmacol       Date:  2016-01-14       Impact factor: 4.335

9.  Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects.

Authors:  Aurora Merovci; Devjit Tripathy; Xi Chen; Ivan Valdez; Muhammad Abdul-Ghani; Carolina Solis-Herrera; Amalia Gastaldelli; Ralph A DeFronzo
Journal:  Diabetes       Date:  2020-10-08       Impact factor: 9.461

10.  Kir6.2 variant E23K increases ATP-sensitive K+ channel activity and is associated with impaired insulin release and enhanced insulin sensitivity in adults with normal glucose tolerance.

Authors:  Dennis T Villareal; Joseph C Koster; Heather Robertson; Alejandro Akrouh; Kazuaki Miyake; Graeme I Bell; Bruce W Patterson; Colin G Nichols; Kenneth S Polonsky
Journal:  Diabetes       Date:  2009-06-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.